首页 | 本学科首页   官方微博 | 高级检索  
   检索      

结核分枝杆菌免疫优势抗原研究进展
引用本文:游晓拢,曾焱华.结核分枝杆菌免疫优势抗原研究进展[J].微生物学免疫学进展,2014(6):60-64.
作者姓名:游晓拢  曾焱华
作者单位:南华大学医学院病原生物学研究所,湖南衡阳421001
基金项目:国家传染病重大专项资助项目(2013ZXl0003006-002)
摘    要:结核病是当今影响人类健康、流行性最广、病死率最高的感染性疾病之一。结核病的诊断和疫苗的构建成为当前的研究热点,筛选出结核分枝杆菌免疫优势抗原是快速准确的诊断结核病及研制安全有效的疫苗的关键。拟对近年来国内外学者发现的结核分枝杆菌免疫优势抗原的分子生物学特性研究进展进行综述。

关 键 词:结核分枝杆菌  免疫优势抗原  疫苗

Advances in immunodominant antigen of Mycobacterium tuberculosis
YOU Xiao-long,ZENG Yan-hua.Advances in immunodominant antigen of Mycobacterium tuberculosis[J].Progress In Microbiology and Immunology,2014(6):60-64.
Authors:YOU Xiao-long  ZENG Yan-hua
Institution:(Institute of Pathogenic Biology, University of South China, Hengyang 421001, Hunan Province, China)
Abstract:Tuberculosis (TB) is one of the leading infectious diseases which can impact on human health, has popular epi- demieity and high mortality rate. The basis research of the tuberculosis diagnosis and vaccines has become a hot topic. Screening out the immunodominant antigen of Mycobacterium tuberculosis is the key to not only timely and accurate diagnosis but also safe and effective vaccines. This paper summarized the progress on the biological characteristics of immunodomi- Rant antigen of Mycobacterium tuberculosis.
Keywords:Mycobacterium tuberculosis  Immunodominant antigen  Vaccine
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号